对癌症药物格列卫耐药性的研究。 - Suppr

Suppr

超能文献

Research on resistance to cancer drug Gleevec.

作者信息

Sawyers C L

出版信息

Science. 2001 Nov 30;294(5548):1834. doi: 10.1126/science.294.5548.1834b.

DOI:10.1126/science.294.5548.1834b

PMID:11732550

Abstract

摘要

相似文献

Research on resistance to cancer drug Gleevec.

Science. 2001 Nov 30;294(5548):1834. doi: 10.1126/science.294.5548.1834b.

Gleevec resistance: lessons for target-directed drug development.

Cell Cycle. 2003 May-Jun;2(3):190-1.

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.

Haematologica. 2007 Mar;92(3):401-4. doi: 10.3324/haematol.10822.

High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.

Blood. 2002 May 1;99(9):3472-5. doi: 10.1182/blood.v99.9.3472.

A novel I293MP mutation within BCR-ABL kinase domain in a Ph-positive acute lymphoblastic leukemia patient presenting resistant to imatinib but sensitive to nilotinib.

Leuk Res. 2012 Aug;36(8):e159-62. doi: 10.1016/j.leukres.2012.04.019. Epub 2012 May 11.

Disappearance of both the BCR/ABL1 fusion gene and the JAK2V617F mutation with dasatinib therapy in a patient with imatinib-resistant chronic myelogenous leukemia.

J Clin Exp Hematop. 2012;52(2):145-7. doi: 10.3960/jslrt.52.145.

Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype.

Leukemia. 2010 Oct;24(10):1817-21. doi: 10.1038/leu.2010.179. Epub 2010 Aug 26.

Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib.

Leukemia. 2005 Jan;19(1):132-4. doi: 10.1038/sj.leu.2403453.

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation.

Haematologica. 2008 Nov;93(11):1718-22. doi: 10.3324/haematol.13207. Epub 2008 Aug 25.

Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation.

Blood. 2002 Mar 1;99(5):1860-2. doi: 10.1182/blood.v99.5.1860.

引用本文的文献

Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration.

Cells. 2021 Jan 29;10(2):262. doi: 10.3390/cells10020262.

Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase.

J Med Chem. 2015 Dec 10;58(23):9228-37. doi: 10.1021/acs.jmedchem.5b01125. Epub 2015 Nov 20.

Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage.

Oncogene. 2015 Aug 6;34(32):4177-89. doi: 10.1038/onc.2014.345. Epub 2014 Oct 27.

Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

PLoS One. 2012;7(5):e35584. doi: 10.1371/journal.pone.0035584. Epub 2012 May 10.

Genomic plasticity of the human fungal pathogen Candida albicans.

Eukaryot Cell. 2010 Jul;9(7):991-1008. doi: 10.1128/EC.00060-10. Epub 2010 May 21.

Targeting chronic myeloid leukemia stem cells.

Curr Hematol Malig Rep. 2010 Apr;5(2):81-7. doi: 10.1007/s11899-010-0043-0.

The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.

PLoS One. 2008;3(11):e3774. doi: 10.1371/journal.pone.0003774. Epub 2008 Nov 20.

On future's doorstep: RNA interference and the pharmacopeia of tomorrow.

J Clin Invest. 2007 Dec;117(12):3612-4. doi: 10.1172/JCI34274.

Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads.

Anal Biochem. 2005 Dec 1;347(1):67-76. doi: 10.1016/j.ab.2005.09.001. Epub 2005 Sep 22.

Evolutionary dynamics of escape from biomedical intervention.

Proc Biol Sci. 2003 Dec 22;270(1533):2573-8. doi: 10.1098/rspb.2003.2539.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验